hydroxyurea has been researched along with Idiopathic Parkinson Disease in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Benserazide is used in the treatment of Parkinson's disease and was noticed to induce gamma globin in preclinical models." | 1.62 | Benserazide as a potential novel fetal hemoglobin inducer: an observational study in non-carriers of hemoglobin disorders. ( Costa, FF; de Azevedo, PC; Fertrin, KY; Leonardo, DP; Olops, L; Piovesana, LG; Santos, MEHP; Tavares, AHJ; Vendrame, F, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Santos, MEHP | 1 |
| Olops, L | 1 |
| Vendrame, F | 1 |
| Tavares, AHJ | 1 |
| Leonardo, DP | 1 |
| de Azevedo, PC | 1 |
| Piovesana, LG | 1 |
| Costa, FF | 1 |
| Fertrin, KY | 1 |
1 other study available for hydroxyurea and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Benserazide as a potential novel fetal hemoglobin inducer: an observational study in non-carriers of hemoglobin disorders.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Sickle Cell; Antiparkinson Agents; Antisickling Agents; Bens | 2021 |